US EditionFY2029 Earnings Estimate for DMAC Issued By HC Wainwright
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
FY2029 Earnings Estimate for DMAC Issued By HC Wainwright
DiaMedica Therapeutics Inc. (NASDAQ:DMAC – Free Report) – Research analysts at HC Wainwright upped their FY2029 earnings per share (EPS) estimates for shares of DiaMedica Therapeutics in a research note issued on Thursday, May 15th. HC Wainwright analyst M. Caufield now forecasts that the company will earn $0.08 per share for the year, up from […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage